From Vision to Action – Launch of Cities@Heart скачать в хорошем качестве

From Vision to Action – Launch of Cities@Heart

Cities@Heart, launched in January 2026, is an IHI-funded public-private partnership addressing the gap between effective cardiovascular disease (CVD) strategies and their limited implementation, particularly in underserved urban communities. The initiative aims to reduce CVD burden and health inequalities through scalable, technology-enabled solutions. Focusing on obesity, hypertension, dyslipidaemia, and diabetes, the project will pilot prevention, early detection, and management programs in seven diverse European cities. #CitiesatHeart #ihi #cardiovascularhealth #healthequity #EuropeanResearch #HealthyCities #PublicPrivatePartnership #innovationinhealth 🔷🔷🔷🔷🔷🔷🔷🔷🔷🔷🔷🔷🔷🔷 We’re proud to launch Cities@Heart, a new programme designed to tackle cardiovascular health inequalities and improve access to healthcare in communities across Europe. In this video, we share the vision behind Cities@Heart: a future where evidence-based prevention, early detection and cutting-edge management of cardiovascular disease are universally acceptable in urban areas regardless of social or personal circumstances.. Cities@Heart brings together a powerful and diverse coalition — researchers, academia, industry, medical societies, patient organisations, international health bodies, and public authorities — united by one goal: transforming cardiovascular care in Europe through bold partnerships and collaborative innovation. We also hear why cities are essential drivers of change, and how this programme aims to support them in acting upstream: embedding health into all policies and making the healthy choice the easiest choice. Watch highlights from the project's kick-off meeting and discover how Cities@Heart aims to help cities lead the way toward a healthier future. 🔷🔷🔷🔷🔷🔷🔷🔷🔷🔷🔷🔷🔷🔷 Cities@Heart is supported by the Innovative Health Initiative Joint Undertaking (IHI JU) under grant agreement No 101219389. The JU receives support from the European Union’s Horizon Europe research and innovation programme and COCIR, EFPIA, Europa Bío, MedTech Europe and Vaccines Europe. ​ Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the aforementioned parties. Neither of the aforementioned parties can be held responsible for them.